{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T08:16:29Z","timestamp":1788682589079,"version":"build-2803163510"},"reference-count":43,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2007,6,7]],"date-time":"2007-06-07T00:00:00Z","timestamp":1181174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2007,7]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Eighty per cent of HIV\u2010positive patients show evidence of past or current infection with hepatitis B virus (HBV). The impact of chronic HBV infection or the presence of isolated HBV core antibody on survival in the era of highly active antiretroviral therapy (HAART) has not been well studied.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This retrospective analysis included patients from the HIV Atlanta Veterans Affairs Cohort Study (HAVACS). This cohort comprises 2818 HIV\u2010positive patients followed since 1982. For this analysis, 1685 patients with available HBV serologies were included, based on laboratory records available since 1992. Adjusted survival analyses were performed for patients showing any of four serological patterns for HBV: (1) surface antigen positive (chronic HBV infection), (2) isolated core antibody, (3) surface antibody with or without core antibody (resolved\/vaccinated) and (4) no HBV markers (negative group). Risk factors for liver disease were identified.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A trend was seen for a lower survival rate from AIDS to death in the chronic HBV infection group compared with the negative group [hazard ratio (HR) 1.43; <jats:italic>P<\/jats:italic>=0.118]. The only independent predictor of lower survival rate was hepatitis C virus positivity (HR 1.62; <jats:italic>P<\/jats:italic>=0.008). Protective factors were use of HAART (HR 0.40; <jats:italic>P<\/jats:italic>=0.0003), use of lamivudine (HR 0.36; <jats:italic>P<\/jats:italic>&lt;0.0001) and use of tenofovir (HR 0.23; <jats:italic>P<\/jats:italic>&lt;0.0001). Survival from HIV diagnosis to death was not different among the HBV groups. Isolated core antibody patients did not have a lower survival rate compared with those with resolved HBV infection. Patients with chronic HBV infection were 3.5 times more likely to have liver disease than those with no HBV infection (<jats:italic>P&lt;<\/jats:italic>0.02).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>There is a trend towards a lower survival rate in patients with HIV and chronic HBV infection, but the difference did not reach statistical significance. The presence of isolated core antibody was not associated with a lower survival rate.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1468-1293.2007.00469.x","type":"journal-article","created":{"date-parts":[[2007,6,7]],"date-time":"2007-06-07T07:34:48Z","timestamp":1181201688000},"page":"271-279","source":"Crossref","is-referenced-by-count":26,"title":["Hepatitis B virus and HIV coinfection: relationship of different serological patterns to survival and liver disease"],"prefix":"10.1111","volume":"8","author":[{"given":"MK","family":"Osborn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JL","family":"Guest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Rimland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,6,7]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)03201-2"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803263381301"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1086\/318501"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1086\/343862"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1089\/08892220152644160"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11913-1"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1047-2797(96)00064-6"},{"key":"e_1_2_5_9_2","first-page":"111","article-title":"Coinfection and superinfection of hepatitis B virus in patients infected with human immunodeficiency virus","volume":"29","author":"Sinicco A","year":"1997","journal-title":"no evidence of faster progression to AIDS"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(97)80274-7"},{"key":"e_1_2_5_11_2","first-page":"597","article-title":"Interactions between HIV and hepatitis B virus in homosexual men","volume":"11","author":"Gilson RJ","year":"1997","journal-title":"effects on the natural history of infection"},{"key":"e_1_2_5_12_2","first-page":"837","article-title":"Hepatitis B in patients with HIV infection","volume":"117","author":"Scharschmidt BF","year":"1992","journal-title":"relationship to AIDS and patient survival"},{"key":"e_1_2_5_13_2","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/oxfordjournals.aje.a117636","article-title":"Prognostic factors for all\u2010cause mortality among hemophiliacs infected with human immunodeficiency virus","volume":"142","author":"Diamondstone LS","year":"1995","journal-title":"Am J Epidemiol"},{"key":"e_1_2_5_14_2","first-page":"127","article-title":"The prevalence of hepatitis B and C in HIV\u2010positive Greek patients","volume":"40","author":"Dimitrakopoulos A","year":"2000","journal-title":"relationship to survival of deceased AIDS patients"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1086\/420744"},{"key":"e_1_2_5_16_2","first-page":"593","article-title":"Hepatitis B and HIV","volume":"19","author":"Konopnicki D","year":"2005","journal-title":"prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort"},{"key":"e_1_2_5_17_2","first-page":"2039","article-title":"Survival in patients with HIV infection and viral hepatitis B or C","volume":"18","author":"Bonacini M","year":"2004","journal-title":"a cohort study"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01719475"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200407010-00015"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2004.00206.x"},{"key":"e_1_2_5_21_2","first-page":"750","article-title":"Occult hepatitis B virus infection in HIV\u2010infected patients with isolated antibodies to hepatitis B core antigen","volume":"40","author":"Neau D","year":"2005","journal-title":"Aquitaine cohort, 2002\u201303"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(02)00019-3"},{"key":"e_1_2_5_23_2","first-page":"1","article-title":"1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults","volume":"41","author":"Centers for Disease Control and Prevention.","year":"1992","journal-title":"MMWR Recomm Rep"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.313.7055.461"},{"key":"e_1_2_5_25_2","first-page":"14","article-title":"Prevalence of hepatitis B virus infection in the United States","volume":"89","author":"McQuillan GM","year":"1999","journal-title":"the National Health and Nutrition Examination Surveys, 1976 through 1994"},{"key":"e_1_2_5_26_2","first-page":"1009","article-title":"Acute flares in chronic hepatitis B","volume":"120","author":"Perrillo RP.","year":"2001","journal-title":"the natural and unnatural history of an immunologically mediated liver disease"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)62892-9"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1086\/421386"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1086\/317535"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1293.2003.00152.x"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200312010-00013"},{"key":"e_1_2_5_32_2","first-page":"14","article-title":"Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection","volume":"23","author":"Jilg W","year":"1995","journal-title":"high percentage of carriers of hepatitis B and C virus"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1086\/375084"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/23.1.189"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365540050165866"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1052"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(05)80407-6"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200210180-00024"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197806222982502"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v113.pm9352871"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199802270-00007"},{"key":"e_1_2_5_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199501270-00014"},{"key":"e_1_2_5_43_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199907013410104"},{"key":"e_1_2_5_44_2","doi-asserted-by":"publisher","DOI":"10.1086\/383155"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1293.2007.00469.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1293.2007.00469.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T02:14:23Z","timestamp":1696904063000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1293.2007.00469.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,7]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["10.1111\/j.1468-1293.2007.00469.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1293.2007.00469.x","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"value":"1464-2662","type":"print"},{"value":"1468-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,7]]}}}